Results with ATRA and Anthracycline Based Chemotherapy (CT) in Acute Promyelocytic Leukemia (APL) in a Developing Country. Should Dose Intensity Be Reduced to Obtain Acceptable Results?

MLA

Ramzi Jeddi, et al. “Results with ATRA and Anthracycline Based Chemotherapy (CT) in Acute Promyelocytic Leukemia (APL) in a Developing Country. Should Dose Intensity Be Reduced to Obtain Acceptable Results?” Blood, vol. 118, Nov. 2011, p. 4271. EBSCOhost, https://doi.org/10.1182/blood.v118.21.4271.4271.

APA

Ramzi Jeddi, Hela Stambouli, Emna Gouider, Yosr Ben Abdennebi, Ramzi Ben Amor, Hela Ben Abid, Samia Menif, Pierre Fenaux, Mohamed Zarrouk, Hend Ben Neji, Raihane Ben Lakhal, Hela Ghedira, Zaher Ben Hadjali, Karima Kacem, Balkis Meddeb, & Lamia Aissaoui. (2011). Results with ATRA and Anthracycline Based Chemotherapy (CT) in Acute Promyelocytic Leukemia (APL) in a Developing Country. Should Dose Intensity Be Reduced to Obtain Acceptable Results? Blood, 118, 4271. https://doi.org/10.1182/blood.v118.21.4271.4271

Chicago

Ramzi Jeddi, Hela Stambouli, Emna Gouider, Yosr Ben Abdennebi, Ramzi Ben Amor, Hela Ben Abid, Samia Menif, et al. 2011. “Results with ATRA and Anthracycline Based Chemotherapy (CT) in Acute Promyelocytic Leukemia (APL) in a Developing Country. Should Dose Intensity Be Reduced to Obtain Acceptable Results?” Blood 118 (November): 4271. doi:10.1182/blood.v118.21.4271.4271.